The U.S. Food and Drug Administration (FDA), a vast government bureaucracy, employs about 17,500 people and had a budget of $5.7 billion in 2019. Yet even with its enormous resources, the FDA these days relies more and more on patients to…
News
The levels of an immunosuppressive protein called human leukocyte antigen G (HLA-G) are significantly higher in the immune cells of people with scleroderma or systemic lupus erythematosus (SLE), suggesting its potential role in controlling impaired immune responses in these diseases, a study has found. However, further studies…
Restoring CCN3 Protein in Skin Could Improve Growth of Blood Vessels in Scleroderma, Study Suggests
Restoring the levels of a protein known as CCN3 in the skin of people with scleroderma may improve the growth of new blood vessels and become a therapeutic target in this chronic disorder, a new study suggests. The study, “Decreased CCN3 in Systemic Sclerosis endothelial cells contributes…
The gleaming new Dutch headquarters of the European Medicines Agency (EMA), fronting Domenico Scarlattilaan in Amsterdam’s suburban Zuidas business district, finally opened for business last month — just over two years after the European Union decided to relocate the EMA to the Netherlands in the wake of Brexit.
Swallowing trouble in people with scleroderma is associated with lower quality of life and a higher incidence of depression, a study found. The study, “Oropharyngeal swallowing functions are impaired in patients with scleroderma,” was published in the journal Clinical and Experimental Rheumatology. Swallowing involves both voluntary and…
Immune players known as dendritic cells play a key role in scleroderma development in the skin and may represent a new target for effective treatments, a mouse study suggests. The study, “Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via…
Localized scleroderma affects health-related quality of life (HRQoL) in young people, causing joint and muscle pain, putting limits on physical activity, and hurting body image, a study found. Teasing from peers, unwanted questions from others, and side effects from treatment were…
Scleroderma patients who develop digital ulcers are more likely to be younger at disease onset, male, and have the diffuse type of the disease, a study has found. Digital ulcers — sores on the fingers and toes — are estimated to affect half of people with scleroderma.
Women with scleroderma take longer to perform daily living tasks, especially those that require hand strength and gripping objects, such as moving things between shelves, a new study found. These findings suggest that incorporating the Glittre Activities of Daily Living test (GA-T) in clinical evaluations may help better…
Genetic testing may allow physicians to better distinguish scleroderma from its overlap syndromes and help to predict the disease’s likely course, a study reports. The study, “Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsets,” was published in the Journal of the European Academy…
Recent Posts
- Dexamethasone reduces inflammation, scarring in SSc mouse model: Study
- Survival improves for SSc-PAH patients on combination therapy
- Combination drug therapy boosts lung, skin health in SSc patients
- On choosing medicine’s side effects over scleroderma progression
- Telerehabilitation improves hand mobility in scleroderma women
- Molecular pathway ID’d as key driver of scarring in scleroderma
- Limited hand function disrupts daily life for people living with SSc
- Coping with loss is part of living with scleroderma
- CAR T-cell therapy eases SSc symptoms, early trial data show
- Milk-derived particles may offer treatment path for SSc fibrosis